Next Generation News and Research

RSS

Dome9 Security announces multi-cloud security management platform

Dome9 Security, the leading provider of cloud security management for public and private clouds, as well as for dedicated and virtual private servers (VPS), today at TechCrunch Disrupt 2011 announced the general availability of its new first-of-its-kind, multi-platform security management service that automates cloud server security for both enterprises and cloud hosting providers.

12 Sep 2011

Women with BRCA gene mutations at risk of developing cancers at earlier ages

A new analysis has found that women who develop certain hereditary cancers develop them at earlier ages than women in the previous generation. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results point to the importance of tracking younger ages of cancer diagnosis to determine when to provide counseling, screening, and treatment services.

12 Sep 2011

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking sales and marketing approval for vismodegib to treat people with advanced basal cell carcinoma (BCC), which includes metastatic and locally advanced BCC for whom surgery is inappropriate.

12 Sep 2011

PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine

PharmAthene, Inc. announced today that it has achieved significant progress in the development of its second generation anthrax vaccine, SparVax.

12 Sep 2011

Researchers uncover new and safe contraceptive pill for women

Oregon Health & Science University researchers have uncovered a new contraceptive that is more focused, safer and, therefore, available for use among a larger population of women.

8 Sep 2011

UM educator named RWJF Nurse Faculty Scholar

Rosa Gonzalez-Guarda, Ph.D., R.N., an assistant professor at the University of Miami, School of Nursing & Health Studies, has won a competitive grant from the Robert Wood Johnson Foundation (RWJF) to develop, manualize, and test an intervention for preventing teen dating violence among Hispanics. Gonzalez-Guarda is one of just 12 nurse educators from around the country to receive the three-year $350,000 Nurse Faculty Scholar award this year.

8 Sep 2011

BARDA awards GlaxoSmithKline contract for development of dual-purpose broad spectrum antibiotic

The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening infections, known as Gram-negative infections, associated with prolonged hospitalization.

7 Sep 2011

Concentric Medical launches Trevo Pro 4 device for acute ischemic stroke

Concentric Medical, Inc. today announced the full European launch of Trevo Pro 4 System. This next standard in Stentriever technology has an enhanced design to further promote clot integration across clot types in patients suffering an acute ischemic stroke.

6 Sep 2011

European Neurotech Investing & Partnering Summit to take place in Helsinki

The inaugural European Neurotech Investing & Partnering Summit takes place in Helsinki this week. It features keynotes on the state of the European neurotech industry, investor analysis, as well as company and research project presentations on next generation treatments emerging in the EU for unmet needs of brain and nervous system disorders like Alzheimer's, addiction, depression, schizophrenia, Parkinson's, Huntington's, stroke and more.

6 Sep 2011

Bruker releases new amaZon speed ion trap mass spectrometers

At the HUPO 10th Annual World Congress in Geneva, Switzerland, and at the JAIMA Conference in Tokyo, Japan, Bruker this week announces the release of its new high-performance amaZon speed and amaZon speed ETD ion trap mass spectrometers (ITMS) to meet the increasing demands of the proteomics, research and applied markets.

6 Sep 2011

Researchers discover gene mutation linked with lymphoedema, leukaemia

Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia.

5 Sep 2011

Medtronic initiates U.S. post-approval study of Endurant AAA Stent Graft System

Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.

From Medtronic 2 Sep 2011

Medivir reports net sales of SEK 444.6 m for 1 January - 30 June 2011

Medivir: Interim period (January 2011 - June 2011). Net sales were SEK 444.6 (35.7) m.

31 Aug 2011

Alcon chooses Bruker ContourGT-X8 Optical Surface Profiler

Bruker announced today that Alcon Corporation has selected the Bruker ContourGT-X8 Optical Surface Profiler to provide non-destructive, non-contact reference metrology for critical dimensioning and 3D characterization of Alcon's current and next-generation intra-ocular lenses.

From Bruker Nano Surfaces and Metrology 30 Aug 2011

Student researchers throughout Australia compete for annual award

Student researchers from throughout Australia will compete for state and national titles in the country’s leading competition for life science, biotechnology and bio-engineering students: the 2011 AusBiotech-GSK Student Excellence Awards. Applications are now open for the 2011 awards.

29 Aug 2011

BioAmber selects Sarnia as location for first North American biosuccinic acid plant

BioAmber Inc., through its subsidiary Bluewater Biochemicals has selected Sarnia, Ontario, Canada as the location for its first North American biosuccinic acid plant. The Sarnia plant will have an initial capacity of 17,000 MT and will be commissioned in 2013. Permitting work for the plant was initiated in June 2011. BioAmber currently produces and sells biobased succinic acid at a 3,000 MT capacity plant in France.

29 Aug 2011

ConversePoint plans to develop, commercialize next generation clinician communications

ConversePoint, a privately owned company based in Chicago, has announced its plans to develop and commercialize a communications platform for the healthcare industry that will significantly save clinicians time, hospitals millions in productivity costs and improve accountability measurements for critical events per the Joint Commission's National Patient Safety Goals along with the license of key Qualcomm technology.

29 Aug 2011

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.

25 Aug 2011

Researchers trace source of latest cholera pandemic

Researchers have used next generation sequencing to trace the source and explain the spread of the latest (seventh) cholera pandemic. They have also highlighted the impact of the acquisition of resistance to antibiotics on shaping outbreaks and show resistance was first acquired around 1982.

25 Aug 2011

MSFHR announces recipients of 2010/11 health research scholar and trainee funding competitions

The Michael Smith Foundation for Health Research (MSFHR) is pleased to announce the recipients of its 2010/11 research scholar and trainee funding competitions. Of the more than 300 applicants, MSFHR has funded 95 individuals working in diverse fields of health research.

24 Aug 2011